Arax Advisory Partners’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$90.3K Hold
24,817
﹤0.01% 976
2025
Q1
$47.6K Buy
24,817
+11,117
+81% +$21.3K ﹤0.01% 961
2024
Q4
$26K Buy
+13,700
New +$26K ﹤0.01% 1110